speb/financial-data huggingface dataset:
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 61996000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 172562000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -4553000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Capital Expenditure Reported: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 53963000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 76880000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 198076000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 1404000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 76880000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Change In Inventory: -116163000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Change In Payable: -12491000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Change In Receivables: -40121000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: -168775000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Changes In Cash: 16288000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Common Stock: 53963000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 781612000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 715985000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Current Assets: 819130000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Current Debt: 137548000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 137548000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 215243000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 2554000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Depreciation: 12847000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 12847000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 12847000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 12847000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 5396250.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Diluted EPS: 1.87
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 10068000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — EBIT: 22354000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — EBITDA: 35201000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — End Cash Position: 78284000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: 51356000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 160177000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: -154343000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -48000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: -118000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 42469000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 906155000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Gross Profit: 165961000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Interest Expense: 8822000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 8822000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Interest Income: 14278000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 14278000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -8822000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 17438000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Inventory: 397244000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 919701000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: 114722000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 5370000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 9746000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 541000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 541000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 17149000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 723847000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Net Debt: 61209000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Net Income: 10068000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 10068000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 10068000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Net Income Discontinuous Operations: 0.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 10068000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 10068000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 13532000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 10068000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Net Interest Income: 2106000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 101456000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 60178000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 541000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: 2106000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Net PPE: 118219000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -4172000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 59637000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 781612000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 628000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 49899000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 17146000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 2642000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: 35105000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Normalized Income: 9996574.64
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: -149790000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Operating Income: -4672000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Operating Revenue: 881946000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 5396250.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 57500000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 6890000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 2500000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 1292000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: -5456000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 9934000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 600000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 64000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 437000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Other Payable: 5848000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 8408000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 121196000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Other Special Charges: -96000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Payables: 57748000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 34136000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Pretax Income: 13532000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: 0.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: -4474000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -4553000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 203124000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 715985000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 12847000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 1781000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 1781000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 23204000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Restructuring And Mergern Acquisition: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 213612000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 105930000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 381000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 66269000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 108738000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Share Issued: 5396250.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Special Income Charges: 48000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 781612000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 781612000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 24574.64
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Tax Provision: 3464000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.26
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 20171000.00
ZENITHEXPO.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -1772000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Total Assets: 1015170000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 782153000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Total Debt: 138089000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 781612000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Total Expenses: 886618000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 233558000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 196040000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 18315000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 3350000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 0.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Total Unusual Items: 96000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 96000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Work In Process: 32651000.00
ZENITHEXPO.NS balance_sheet (annual, 2022-03-31) — Working Capital: 603887000.00
ZENITHEXPO.NS income_statement (annual, 2022-03-31) — Write Off: 48000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — +Operating Expense: 142528000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — +Total Revenue: 600835000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 59573000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 92622000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -798360000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 27737000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 8491000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 5396250.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Basic EPS: 2.92
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 78284000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 167013000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -1666000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Capital Expenditure Reported: -52000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 53963000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 65225000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 284426000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 29500000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 35725000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 120041000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Change In Payable: 11702000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 52246000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 183989000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -13058000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Common Stock: 53963000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 797280000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 0.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 466544000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Current Assets: 717779000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Current Debt: 94739000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 94739000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 185068000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 922000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Depreciation: 13031000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 13031000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 13031000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 13031000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 5396250.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Diluted EPS: 2.92
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 15778000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — EBIT: 26500000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — EBITDA: 39531000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — End Cash Position: 65226000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -49847000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 164375000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 190648000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -289000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -10181000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 35347000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 897660000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Gross Profit: 134291000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Interest Expense: 6497000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 6497000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Interest Income: 19952000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 19952000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -6497000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 17871000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Inventory: 277203000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 892019000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -155525000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 8491000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 9315000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 17200000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 721332000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Net Debt: 29514000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Net Income: 15778000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 15778000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 15778000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Net Income Discontinuous Operations: 0.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 15778000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 15778000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 20003000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 15778000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Net Interest Income: 9246000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -189413000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -43350000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -541000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 9246000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -100000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Net PPE: 99300000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: 16069000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -42809000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 797280000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 551000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 45712000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 17212000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 2427000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 32868000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Normalized Income: 10522347.65
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 192314000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Operating Income: -8237000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Operating Revenue: 600835000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 5396250.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 54400000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 5807000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 2500000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 1194000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -13455000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 7650000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 500000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 754000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 4278000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Other Payable: 6393000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 9057000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 219201000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Other Special Charges: -9629000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Payables: 65966000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2747000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 31721000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Pretax Income: 20003000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 922000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -196771000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -1614000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 85005000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 466544000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 13031000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 1723000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 1723000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 1404000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Restructuring And Mergern Acquisition: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 229390000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 7358000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 17683000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 34534000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 69881000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Share Issued: 5396250.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Special Income Charges: 6374000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 797280000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 797280000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 1407347.65
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Tax Provision: 4225000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.21
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 21346000.00
ZENITHEXPO.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -1706000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Total Assets: 1000111000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 797280000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Total Debt: 94739000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 797280000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Total Expenses: 609072000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 202831000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 282332000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 17763000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 4209000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 0.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 6663000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 6663000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Work In Process: 26629000.00
ZENITHEXPO.NS balance_sheet (annual, 2023-03-31) — Working Capital: 532711000.00
ZENITHEXPO.NS income_statement (annual, 2023-03-31) — Write Off: 3255000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — +Operating Expense: 147267000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — +Total Revenue: 785139000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 56422000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 143661000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -803411000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 27737000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 39174000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 5396250.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Basic EPS: 0.56
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 65226000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 167013000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -5862000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Capital Expenditure Reported: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 53963000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 121453000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 250540000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 108370000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 13083000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -1265000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Change In Payable: -6111000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -57132000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -64508000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 56227000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Common Stock: 53963000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 802546000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 510000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 653212000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Current Assets: 749626000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Current Debt: 54723000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 54723000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 135851000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 3100000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Depreciation: 10130000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 10130000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 10130000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 10130000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 5396250.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Diluted EPS: 0.56
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 3032000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — EBIT: 15694000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — EBITDA: 25824000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — End Cash Position: 121453000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -48416000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 155967000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -71557000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -13000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 274000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 39414000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 895473000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Gross Profit: 131927000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Interest Expense: 9061000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 9061000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Interest Income: 23864000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 23864000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -9061000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 19114000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Inventory: 278467000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 857930000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: 170338000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 39174000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 9315000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 661000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 661000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 19300000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 718635000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Net Income: 3032000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 3032000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 3032000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Net Income Discontinuous Operations: 0.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 3032000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 3032000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 6633000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 3032000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Net Interest Income: 11454000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 152384000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -39355000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 661000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 11454000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 2007000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Net PPE: 92062000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -3167000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -40016000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 802546000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 551000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 41340000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 19326000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 2457000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 26661000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Normalized Income: 3617900.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: -65695000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Operating Income: -15340000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Operating Revenue: 785139000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 5396250.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 63000000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 7360000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 5500000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 2975000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -14803000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 7457000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 600000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 507000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 4761000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Other Payable: 7622000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Other Properties: 91600000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 15280000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 129087000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Other Special Charges: 605000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Payables: 64044000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 3106000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 34800000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Pretax Income: 6633000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: -922000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -2266000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -5862000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 97036000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 653212000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 10130000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 2681000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 2681000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 1404000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Restructuring And Mergern Acquisition: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 229360000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 154650000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 2695000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 35214000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 74628000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Share Issued: 5396250.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Special Income Charges: -850000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 802546000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 802546000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -251100.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Tax Provision: 3601000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.30
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 25474000.00
ZENITHEXPO.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -2486000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Total Assets: 958991000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 803207000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Total Debt: 55384000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 802546000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Total Expenses: 800479000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 156445000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 209365000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 20594000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 3349000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 0.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -837000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -837000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Tradeand Other Payables Non Current: 56000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Work In Process: 22489000.00
ZENITHEXPO.NS balance_sheet (annual, 2024-03-31) — Working Capital: 613775000.00
ZENITHEXPO.NS income_statement (annual, 2024-03-31) — Write Off: 245000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 63100000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 156500000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 47200000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 5398458.00
ZENITHEXPO.NS income_statement (quarterly, 2024-09-30) — Basic EPS: -3.89
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 54000000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 141800000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 282800000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 54000000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 783400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 804700000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 96200000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 96200000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 191500000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 1700000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 5398458.00
ZENITHEXPO.NS income_statement (quarterly, 2024-09-30) — Diluted EPS: -3.89
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 0.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 92500000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 287700000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 880000000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 47200000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 23700000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-09-30) — Net Income Discontinuous Operations: 0.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 92500000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 783400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 46800000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 5396250.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 77700000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 16900000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 729400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 7400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 700000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 92500000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 141000000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Payables: 63100000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 5396250.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 783400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 783400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 999700000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 783800000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 96600000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 783400000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 216300000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 195000000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 24800000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 0.00
ZENITHEXPO.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 613200000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 78300000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 185700000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 5403226.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 1.24
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 106200000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 2100000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 2100000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 5403226.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 1.24
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 6700000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — EBIT: 11200000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — EBITDA: 13300000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 79500000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 2100000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 2100000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Net Income: 6700000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 6700000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 6700000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 6700000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 6700000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 6700000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -2100000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -2100000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 13300000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 6700000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Operating Income: 1200000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 185700000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 10000000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 53800000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 9100000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 106200000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 2100000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 2400000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.26
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 184500000.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
ZENITHEXPO.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — +Operating Expense: 325600000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 89000000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — +Total Revenue: 721000000.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 208900000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 56398000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 56398000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 176019000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 176019000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -805154000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -805154000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 27737000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 27737000.00
ZENITHEXPO.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 60282000.00
ZENITHEXPO.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 60282000.00
ZENITHEXPO.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 5394322.00
ZENITHEXPO.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 5405405.00